Sort   by:  
 Page size 
UnknownSafety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.
Not available
S-EPMC4878046 | biostudies-literature
UnknownHigh-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Not available
S-EPMC8458687 | biostudies-literature
UnknownVariables Associated with Coronavirus Disease 2019 Vaccine Hesitancy Amongst Patients with Neurological Disorders.
Not available
S-EPMC8482072 | biostudies-literature
UnknownTime to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis.
Not available
S-EPMC10851137 | biostudies-literature
UnknownEstimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.
Not available
S-EPMC3953880 | biostudies-literature
UnknownNeuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.
Not available
S-EPMC12015082 | biostudies-literature
UnknownFour-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Not available
S-EPMC8282329 | biostudies-literature
UnknownRisk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Not available
S-EPMC11526018 | biostudies-literature
UnknownTowards cascading genetic risk in Alzheimer's disease.
Not available
S-EPMC11292901 | biostudies-literature
UnknownHNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder.
Not available
S-EPMC10432175 | biostudies-literature
Sort   by:  
 Page size